Alexion Pharmaceuticals Enterprise Account Executive Salary
The average Alexion Pharmaceuticals Enterprise Account Executive earns an estimated $64,860 annually, which includes an estimated base salary of $61,610 with a $3,250 bonus. Alexion Pharmaceuticals' Enterprise Account Executive compensation is $48,614 less than the US average for a Enterprise Account Executive. Enterprise Account Executive salaries at Alexion Pharmaceuticals can range from $35,500 - $93,500.
The Business Development Department at Alexion Pharmaceuticals earns $484 more on average than the Marketing Department.
Last updated 2 years ago.
- $61,610
- avg. base
- $3,250
- avg. bonus
Enterprise Account Executive Salaries at Alexion Pharmaceuticals
Enterprise Account Executives earn $1,596 more than Account Executives, and $48,862 less than Account Managers.
Compensation at Alexion Pharmaceuticals by Department
The Business Development Department averages $484 more than the Marketing Department, and $5,887 less than the IT Department
Enterprise Account Executive Compensation by Gender (All Companies)
The average female Enterprise Account Executive at companies similar size to Alexion Pharmaceuticals reported making $102,476, while the average male Enterprise Account Executive at similar sized companies reported making $112,728.
Enterprise Account Executive Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Enterprise Account Executive at companies similar size to Alexion Pharmaceuticals reported making $141,122, while the average African American/Black Enterprise Account Executive at similar sized companies reported making $73,075.
How Enterprise Account Executives at Alexion Pharmaceuticals Rate Their Compensation
The majority of Enterprise Account Executives at Alexion Pharmaceuticals believe they're compensated fairly. 100% of Enterprise Account Executives at Alexion Pharmaceuticals say they receive annual bonuses, and the vast majority (71%) are satisfied with their benefits. See more compensation ratings at Alexion Pharmaceuticals
